Novonesis
-
Novonesis to invest US$704.8M in advanced enzyme production facility in India
The investment is designed to increase production capacity, support growing global demand for biosolutions and strengthen the resilience and flexibility of the company’s international supply network.
-
Novonesis, TurtleTree partner to support commercialization of lactoferrin
Simultaneously, Novonesis is making a minor investment into TurtleTree. 321Catalyst Ventures, the CVC-arm of Mitsui Chemicals, Inc. (HQ: Tokyo) joins the investment.
-
Novonesis launches Bovacillus probiotic to boost dairy feed efficiency & milk yield
The launch is supported by 9 peer-reviewed publications, 12 mode-of-action studies and 5 years of field data, reflecting a broader industry shift toward scientifically validated feed additives.
-
Novonesis achieves 100% renewable electricity across global operations
By eliminating reliance on fossil-fuel-based electricity, the company strengthens its environmental credentials and sets a benchmark for the broader biotechnology and industrial sectors.
-
Novonesis reports 8% sales growth in first nine months of 2025
This performance underscores Novonesis’s stability and strategic momentum in the biosolutions space
